Lotte M.E. Berghauser Pont

Clinical Factors Associated With Outcome in Chronic Subdural Hematoma

Lotte M.E. Berghauser Pont, Rúben Dammers, Joost W. Schouten et al. · Neurosurgery · 2011 · 89 citations

Medicine, Neurosurgery, Surgery +14

The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells

Lotte M.E. Berghauser Pont, Anne Kleijn, Jenneke J. Kloezeman et al. · PLoS ONE · 2015 · 51 citations · Full text

Medicine, Oncology, Pharmacology +16

DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells

Lotte M.E. Berghauser Pont, Kishan A.T. Naipal, Jenneke J. Kloezeman et al. · Cancer Letters · 2014 · 44 citations

Medicine, Oncology, Pharmacology +16

Ambivalence among neurologists and neurosurgeons on the treatment of chronic subdural hematoma: a national survey

Lotte M.E. Berghauser Pont, Diederik W.J. Dippel, Bon H. Verweij et al. · Acta Neurologica Belgica · 2012 · 40 citations

Medicine, Neurology, Neurosurgery +9

The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells

Lotte M.E. Berghauser Pont, Jochem K. H. Spoor, Subramanian Venkatesan et al. · Genes & Cancer · 2014 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17